eWEEK content and product recommendations are editorially independent. We may make money when you click on links to our partners. Learn More.
McAfee and BMCSoftware have agreed to work together to integrate BMC’s BladeLogic Client Automation with McAfee’s policy and security management products.
The idea behind the partnership is to bring enterprise IT operations and security management together to eliminate communication gaps, reduce IT costs and remediate client security violations. As part of the alliance, the companies will bring BladeLogic Client Automation together with McAfee’s Policy Auditor, ePolicy Orchestrator and security and remediation content from McAfee Labs.
“By bringing IT operations and security together in a single, integrated solution, we are removing the element of conflict and ensuring both IT and security are aligned based on the needs of the business,” said Dev Ittycheria, BMC’s president of Enterprise Service Management, in a statement. “In addition to increasing compliance and speed to remediation, the integration can also drive down IT costs by reducing the amount of resources required to maintain systems integrity.”
BMCBladeLogic Client Automation configures and automates the rollout of software, patches, power settings and security policies available through McAfee Policy Auditor’w policy remediation library. By streamlining and automating client configuration management, remediation and patches can be rolled out much faster than with previous “disconnected” processes, officials at McAfee and BMCcontend.
“This alliance represents a significant step forward in providing customers with a complete solution for continuous compliance,” said George Kurtz, senior vice president and general manager of McAfee’s risk and compliance business unit, in a statement. “Our joint customers – especially those required to meet stringent compliance guidelines such as SCAP, FDCCand HIPAA – can feel confident that this integration will enable faster, more consistent remediation, achieve operational efficiencies and reduce risk.”
The joint solution is slated to be available in the fourth quarter.